Lerodalcibep Shows Promise in HoFH Phase 3 Study
LIB Therapeutics‘ Phase 3 LIBerate-HoFH study results for lerodalcibep, a novel PCSK9 inhibitor, in patients with homozygous familial hypercholesterolemia...
Pediatric Erydex Safety in Ataxia-Telangiectasia: Long-Term Study Results
Quince Therapeutics announced the publication of long-term safety data from Ataxia-Telangiectasia (A-T) patients treated with EryDex for at least...
hVIVO and ILIAD Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine
ILiAD Biotechnologies and hVIVO will collaborate on a Phase 3 human challenge trial for ILiAD’s next-generation intranasal pertussis vaccine,...
RenovoRx ASCO GI 2025: Promising Pharmacokinetic Data
RenovoRx announced promising pharmacokinetic data from a sub-study of its ongoing Phase III TIGeR-PaC clinical trial, investigating its Trans-Arterial...
FDA Grants Cartesian Special Protocol for Phase 3 Trial in Myasthenia Gravis
Cartesian Therapeutics (NASDAQ: RNAC) received FDA approval under the Special Protocol Assessment (SPA) process for the Phase 3 AURORA...
Adagene Announces Updated Data From Phase 1b/2 Study of Muza in Colorectal Cancer at ASCO GI
Adagene Inc. announced positive updated clinical data for ADG126 (muzastotug), an anti-CTLA-4 SAFEbody® drug, combined with pembrolizumab in a...
Ocugen’s OCU500 Inhaled COVID-19 Vaccine Enters Phase 1 Trial
Ocugen has received FDA approval to begin a Phase 1 clinical trial for OCU500, an inhaled and nasal spray...
Novotech Publishes Comprehensive Report on Oncolytic Virus Therapy
Novotech, a full-service international contract research organization (CRO), released a white paper analyzing global clinical trial trends in oncolytic...
Allurion Raises $7.4M in At-the-Market Offering
Allurion Technologies, a company focused on obesity treatment, announced a registered direct offering of 1,240,000 shares of common stock...
Keytruda Plus Lenvima with Chemo in Gastroesophageal Adenocarcinoma Trial Update
Merck and Eisai announced results from the Phase 3 LEAP-015 trial, which examined the efficacy of Keytruda plus Lenvima...